$UG
UNITED GUARDIAN INC Stock $ug

$ug Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000117184323001846 Filed on March 23, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$2.570M	$2.763M	$12.70M
YoY Change	-33.96%	-24.53%	-8.84%
Cost Of Revenue	$1.094M	$1.516M	$5.996M
YoY Change	-36.05%	-3.23%	4.32%
Gross Profit	$1.477M	$1.246M	$6.702M
YoY Change	-32.33%	-40.47%	-18.08%
Gross Profit Margin	57.45%	45.11%	52.78%
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development	$127.0K	$125.9K	$490.8K
YoY Change	-3.57%	-2.84%	2.53%
% of Gross Profit	8.6%	10.1%	7.32%
Depreciation & Amortization	$24.46K	$32.55K	$135.4K
YoY Change	-28.61%	-16.65%	-7.25%
% of Gross Profit	1.66%	2.61%	2.02%
Operating Expenses	$127.0K	$600.7K	$490.8K
YoY Change	-3.57%	-18.47%	2.53%
Operating Profit	$831.8K	$645.8K	$4.037M
YoY Change	-44.69%	-52.42%	-28.76%
Interest Expense	$120.3K	$198.5K	-$809.6K
YoY Change	-134.08%	329.03%	-483.96%
% of Operating Profit	14.47%	30.74%	-20.05%
Other Income/Expense, Net	$120.3K		-$809.6K
YoY Change	-134.08%		-483.97%
Pretax Income	$952.2K	$844.3K	$3.228M
YoY Change	-17.26%	-39.84%	-45.09%
Income Tax	$196.1K	$165.1K	$658.2K
% Of Pretax Income	20.59%	19.55%	20.39%
Net Earnings	$756.1K	$679.2K	$2.570M
YoY Change	-17.05%	-39.16%	-44.84%
Net Earnings / Revenue	29.42%	24.58%	20.23%
Basic Earnings Per Share	$0.16		$0.56
Diluted Earnings Per Share	$0.16	$0.15	$0.56
COMMON SHARES
Basic Shares Outstanding	4.594M	4.594M	4.594M
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.972M	$6.484M	$6.484M
YoY Change	-10.57%	-20.6%	-20.6%
Cash & Equivalents	$1.202M	$830.5K	$830.5K
Short-Term Investments	$5.770M	$5.654M	$5.654M
Other Short-Term Assets	$319.5K	$387.1K	$387.1K
YoY Change	-31.67%	100.99%	100.99%
Inventory	$2.470M	$1.672M	$1.672M
Prepaid Expenses
Receivables	$1.481M	$1.428M	$1.428M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.24M	$9.971M	$9.971M
YoY Change	-8.69%	-13.92%	-13.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$537.3K	$559.2K	$559.2K
YoY Change	-14.64%	-15.13%	-15.13%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$161.1K	$110.5K	$110.5K
YoY Change
Total Long-Term Assets	$698.4K	$669.7K	$669.7K
YoY Change	10.95%	1.65%	1.65%
TOTAL ASSETS
Total Short-Term Assets	$11.24M	$9.971M	$9.971M
Total Long-Term Assets	$698.4K	$669.7K	$669.7K
Total Assets	$11.94M	$10.64M	$10.64M
YoY Change	-7.73%	-13.09%	-13.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$441.5K	$30.42K	$30.42K
YoY Change	20.04%	-92.6%	-92.6%
Accrued Expenses	$1.314M	$1.322M	$1.322M
YoY Change	-14.31%	-18.76%	-18.76%
Deferred Revenue	$140.8K	$0.00
YoY Change	59.01%	-100.0%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.918M	$1.374M	$1.374M
YoY Change	-4.62%	-41.24%	-41.24%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.918M	$1.374M	$1.374M
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.918M	$1.374M	$1.374M
YoY Change	-13.17%	-43.26%	-43.26%
SHAREHOLDERS EQUITY
Retained Earnings	$9.563M	$8.807M
YoY Change	-6.91%	-5.92%
Common Stock	$459.4K	$459.4K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.02M	$9.267M	$9.267M
YoY Change
Total Liabilities & Shareholders Equity	$11.94M	$10.64M	$10.64M
YoY Change	-7.73%	-13.09%	-13.09%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$756.1K	$679.2K	$2.570M
YoY Change	-17.05%	-39.16%	-44.84%
Depreciation, Depletion And Amortization	$24.46K	$32.55K	$135.4K
YoY Change	-28.61%	-16.65%	-7.25%
Cash From Operating Activities	$417.6K	$624.7K	$2.525M
YoY Change	1423.21%	-62.47%	-52.47%
INVESTING ACTIVITIES
Capital Expenditures	$2.582K	$15.01K	$75.18K
YoY Change	-46.65%	-143.66%	-35.4%
Acquisitions
YoY Change
Other Investing Activities	-$43.51K	$1.148M	$972.7K
YoY Change	2.88%	-3.87%	-1549.69%
Cash From Investing Activities	-$46.09K	$1.133M	$897.6K
YoY Change	-2.21%	-2.32%	-589.2%
FINANCING ACTIVITIES
Cash Dividend Paid	$0.00		$3.123M
YoY Change			-39.82%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	-1.424M	-$3.123M
YoY Change		-52.3%	-39.82%
NET CHANGE
Cash From Operating Activities	$417.6K	624.7K	$2.525M
Cash From Investing Activities	-$46.09K	1.133M	$897.6K
Cash From Financing Activities	$0.00	-1.424M	-$3.123M
Net Change In Cash	$371.5K	333.9K	$299.2K
YoY Change	-1984.55%	-307.79%	-596.82%
FREE CASH FLOW
Cash From Operating Activities	$417.6K	$624.7K	$2.525M
Capital Expenditures	$2.582K	$15.01K	$75.18K
Free Cash Flow	$415.0K	$609.7K	$2.450M
YoY Change	1738.35%	-64.11%	-52.86%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	20063	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	20252	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.10
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4594319
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4594319
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4594319
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4594319
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	ug	Number Of Vendors NumberOfVendors	6	pure
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	usd
CY2021	ug	Defined Contribution Plan Employer Discretionary Contribution Amount Per Year Authorized DefinedContributionPlanEmployerDiscretionaryContributionAmountPerYearAuthorized	109000	usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	1-10526
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-1719724
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	230 Marcus Blvd.
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Hauppauge
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11788
CY2022	dei	City Area Code CityAreaCode	631
CY2022	dei	Local Phone Number LocalPhoneNumber	273-0900
CY2022	dei	Security12b Title Security12bTitle	Common Stock, $.10 par value
CY2022	dei	Trading Symbol TradingSymbol	UG
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	68868800	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	4594319
CY2022	dei	Auditor Firm AuditorFirmId	23
CY2022	dei	Auditor Name AuditorName	Baker Tilly US, LLP
CY2022	dei	Auditor Location AuditorLocation	Uniondale, NY
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12698503	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13929629	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5996376	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5747931	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2174127	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2035970	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	490770	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	478642	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	8661273	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	8262543	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	4037230	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	5667086	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	236695	usd
CY2021	us-gaap	Investment Income Net InvestmentIncomeNet	233857	usd
CY2022	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1046245	usd
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-23018	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-809550	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	210839	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3227680	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5877925	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	658168	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1219383	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2569512	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4658542	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.01
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4594319
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4594319
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	830452	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	531213	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	5653516	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	7635463	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1427576	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1813346	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672012	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1410789	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	201846	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	192579	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	185228	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	9970630	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	11583390	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	110544	usd
CY2022Q4	us-gaap	Land Land	69000	usd
CY2021Q4	us-gaap	Land Land	69000	usd
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	4585055	usd
CY2021Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	4605742	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2895742	usd
CY2021Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2853718	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7549797	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7528460	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6990636	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	6869598	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	559161	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	658862	usd
CY2022Q4	us-gaap	Assets Assets	10640335	usd
CY2021Q4	us-gaap	Assets Assets	12242252	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	30415	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	410894	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1322056	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1627390	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	190164	usd
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	88738	usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	21220	usd
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	20575	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1373691	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2337761	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	83222	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	459432	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	459432	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	8807212	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	9361837	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9266644	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9821269	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10640335	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	12242252	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	10354307	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4658542	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9821269	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2569512	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	9266644	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2569512	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	4658542	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	135396	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	145977	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-2445	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	14799	usd
CY2022	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-1046245	usd
CY2021	us-gaap	Marketable Securities Realized Gain Loss MarketableSecuritiesRealizedGainLoss	-23018	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-189	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	6235	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	29000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-193766	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-68462	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-385959	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	431883	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	290223	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4984	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9267	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	31371	usd
CY2022	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	185228	usd
CY2021	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-99107	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-380479	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	379094	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-305334	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	263933	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-190164	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	190164	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-88738	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	88738	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2525169	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5313277	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	75179	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	116375	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	37039	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	1931969	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	4219760	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2867671	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	4152660	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	897562	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-183475	usd
CY2022	us-gaap	Payments Of Dividends PaymentsOfDividends	3123492	usd
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	5190033	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3123492	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5190033	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	299239	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-60231	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	531213	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	591444	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	830452	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	531213	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1125000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1100000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	645	usd
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1547	usd
CY2021	ug	Tradein Received From Sale Of Asset TradeinReceivedFromSaleOfAsset	29000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><span style="text-decoration: underline; ">Use of Estimates</span></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In preparing financial statements in conformity with a Generally Accepted Accounting Principles in the United States of America (“US GAAP”), management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenue and expenses during the reporting period. Actual results could differ from those estimates. Such estimated items include the allowance for bad debts, reserve for inventory obsolescence, accrued distribution fees, outdated material returns, possible impairment of marketable securities and the allocation of overhead.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"/>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	20063	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	20252	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	190164	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	0	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12698503	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13929629	usd
CY2021Q4	ug	Debt Securities Held To Maturity And Equity Securities Fvni Cost DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost	7466168	usd
CY2021Q4	ug	Debt Securities Held To Maturity And Equity Securities Fvni Fair Value DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue	7635463	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12698503	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13929629	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	105000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.37
CY2022Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.31
CY2022	us-gaap	Dividends Dividends	3124137	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	3123492	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	645	usd
CY2021Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.48
CY2021Q4	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.65
CY2021	us-gaap	Dividends Dividends	5191580	usd
CY2021	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	5190033	usd
CY2021Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1547	usd
CY2021Q4	ug	Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss	169295	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	2867671	usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><span style="text-decoration: underline; ">Concentration of Credit Risk</span></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">Accounts receivable potentially exposes the Company to concentrations of credit risk. The Company monitors the amount of credit it allows each of its customers, using the customer’s prior payment history to determine how much credit to allow or whether any credit should be given at all. It is the Company’s policy to discontinue shipments to any customer that is substantially past due on its payments. The Company sometimes requires payment in advance from customers whose payment record is questionable. As a result of its monitoring of the outstanding credit allowed for each customer, as well as the fact that the majority of the Company’s sales are to customers whose satisfactory credit and payment record has been established over a long period of time, the Company believes that its accounts receivable credit risk has been reduced.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For the year ended <em style="font: inherit;"> December 31, 2022, </em><span style="-sec-ix-hidden:c95656233">four</span> of the Company’s pharmaceutical wholesalers and cosmetic ingredient distributors accounted for approximately 72% of the Company’s gross sales during the year and approximately 81% of its outstanding accounts receivable at <em style="font: inherit;"> December 31, 2022. </em>For the year ended <em style="font: inherit;"> December 31, 2021, </em>the same four pharmaceutical wholesalers and cosmetic ingredient distributors accounted for a total of approximately 75% of the Company’s gross sales during the year and 80% of its outstanding accounts receivable at <em style="font: inherit;"> December 31, 2021.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"/>
CY2021	ug	Number Of Vendors NumberOfVendors	6	pure
CY2022	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	-364074	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	4152660	usd
CY2021	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	111917	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	19000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	31000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	437775	usd
CY2022Q4	ug	Deferred Tax Liabilities Accounts Receivable DeferredTaxLiabilitiesAccountsReceivable	304004	usd
CY2021Q4	ug	Deferred Tax Liabilities Accounts Receivable DeferredTaxLiabilitiesAccountsReceivable	385056	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	830452	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	531213	usd
CY2022	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-1046245	usd
CY2021	us-gaap	Debt And Equity Securities Gain Loss DebtAndEquitySecuritiesGainLoss	-23018	usd
CY2022	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	-364074	usd
CY2021	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	111917	usd
CY2022	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-682171	usd
CY2021	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-134935	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	6166392	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	5653516	usd
CY2022Q4	ug	Equity Securities Fvni Accumulated Unrealized Gain Loss EquitySecuritiesFvniAccumulatedUnrealizedGainLoss	-512876	usd
CY2022Q4	ug	Debt Securities Held To Maturity And Equity Securities Fvni Cost DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNICost	6166392	usd
CY2022Q4	ug	Debt Securities Held To Maturity And Equity Securities Fvni Fair Value DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIFairValue	5653516	usd
CY2022Q4	ug	Debt Securities Held To Maturity And Equity Securities Fvni Unrealized Gain Loss DebtSecuritiesHeldToMaturityAndEquitySecuritiesFVNIUnrealizedGainLoss	-512876	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni Cost EquitySecuritiesFvNiCost	7466168	usd
CY2021Q4	us-gaap	Equity Securities Fv Ni EquitySecuritiesFvNi	7635463	usd
CY2021Q4	ug	Equity Securities Fvni Accumulated Unrealized Gain Loss EquitySecuritiesFvniAccumulatedUnrealizedGainLoss	169295	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	601125	usd
CY2021Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	494348	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	16520	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	119069	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	1054367	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	797372	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1672012	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	1410789	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	64000	usd
CY2021Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	35000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	850344	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1287749	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1590	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	96	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	851934	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1287845	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-193766	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-68462	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-193766	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-68462	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	658168	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1219383	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	42446	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	38918	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	44812	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	61471	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Unrealized Gains On Trading Securities DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities	35552	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	677813	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1234364	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210	pure
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1256	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	76	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	10000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.003	pure
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Research And Development IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment	10000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	0.002	pure
CY2022	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	6300	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Deductions Dividends EffectiveIncomeTaxRateReconciliationDeductionsDividends	0.002	pure
CY2021	us-gaap	Income Tax Reconciliation Deductions Dividends IncomeTaxReconciliationDeductionsDividends	2923	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Deductions Dividends EffectiveIncomeTaxRateReconciliationDeductionsDividends	0.001	pure
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-4601	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.001	pure
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2134	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	658168	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.204	pure
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1219383	usd
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.207	pure
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	4213	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	4253	usd
CY2022Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	13440	usd
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	7350	usd
CY2022Q4	ug	Deferred Tax Assets Accounts Payable DeferredTaxAssetsAccountsPayable	6367	usd
CY2021Q4	ug	Deferred Tax Assets Accounts Payable DeferredTaxAssetsAccountsPayable	86288	usd
CY2022Q4	ug	Deferred Tax Assets Capitalized Research And Development DeferredTaxAssetsCapitalizedResearchAndDevelopment	92756	usd
CY2022Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Availablefor Sale Securities Gross DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross	107704	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	277326	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	339884	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	501806	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	391262	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	520997	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	110544	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	83222	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	81000	usd
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	80000	usd
CY2022	ug	Defined Contribution Plan Employer Discretionary Contribution Amount Per Year Authorized DefinedContributionPlanEmployerDiscretionaryContributionAmountPerYearAuthorized	109000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2022	ug	Revenue From Contract With Customer Including Assessed Tax Gross RevenueFromContractWithCustomerIncludingAssessedTaxGross	13905962	usd
CY2021	ug	Revenue From Contract With Customer Including Assessed Tax Gross RevenueFromContractWithCustomerIncludingAssessedTaxGross	14947167	usd
CY2022	ug	Sales Returns And Allowances SalesReturnsAndAllowances	1207459	usd
CY2021	ug	Sales Returns And Allowances SalesReturnsAndAllowances	1017538	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12698503	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13929629	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12698503	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13929629	usd
CY2022	ug	Revenue From Contract With Customer Including Assessed Tax Gross RevenueFromContractWithCustomerIncludingAssessedTaxGross	13905962	usd
CY2021	ug	Revenue From Contract With Customer Including Assessed Tax Gross RevenueFromContractWithCustomerIncludingAssessedTaxGross	14947167	usd
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	175496	usd
CY2021Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	348000	usd
CY2022Q4	ug	Accrued Distribution Fees Current AccruedDistributionFeesCurrent	395536	usd
CY2021Q4	ug	Accrued Distribution Fees Current AccruedDistributionFeesCurrent	359550	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	53475	usd
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	292560	usd
CY2022Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	94326	usd
CY2021Q4	us-gaap	Pension And Other Postretirement Defined Benefit Plans Current Liabilities PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities	109000	usd
CY2022Q4	ug	Accrued Annual Report Expenses Current AccruedAnnualReportExpensesCurrent	68349	usd
CY2021Q4	ug	Accrued Annual Report Expenses Current AccruedAnnualReportExpensesCurrent	64038	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	66500	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	61500	usd
CY2022Q4	ug	Accrued Reserve For Outdated Material AccruedReserveForOutdatedMaterial	369154	usd
CY2021Q4	ug	Accrued Reserve For Outdated Material AccruedReserveForOutdatedMaterial	313904	usd
CY2022Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	80926	usd
CY2021Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	56857	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	18294	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	21981	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1322056	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1627390	usd
CY2022Q4	ug	Convertible Common Stock Shares Issuable Upon Conversion ConvertibleCommonStockSharesIssuableUponConversion	447
CY2022	ug	Payments For Accrued Dividends On Unconverted Shares PaymentsForAccruedDividendsOnUnconvertedShares	447	usd

Files In Submission

Name	View Source	Status
0001171843-23-001846-index-headers.html	Edgar Link	pending
0001171843-23-001846-index.html	Edgar Link	pending
0001171843-23-001846.txt	Edgar Link	pending
0001171843-23-001846-xbrl.zip	Edgar Link	pending
ex_488286.htm	Edgar Link	pending
ex_488287.htm	Edgar Link	pending
ex_488288.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ug-20221231.xsd	Edgar Link	pending
ug20221231_10k.htm	Edgar Link	pending
ug-20221231_lab.xml	Edgar Link	unprocessable
ug-20221231_pre.xml	Edgar Link	unprocessable
ug20221231_10k_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
ug-20221231_def.xml	Edgar Link	unprocessable
ug-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UG
UNITED GUARDIAN INC Stock $ug

2023 Q1 Form 10-K Financial Statement

#000117184323001846 Filed on March 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UG UNITED GUARDIAN INC Stock $ug

2023 Q1 Form 10-K Financial Statement

#000117184323001846 Filed on March 23, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UG
UNITED GUARDIAN INC Stock $ug